The rapid, massive growth of COVID-19 authors in the scientific literature.
COVID-19
authorship
bibliometrics
citations
productivity
Journal
Royal Society open science
ISSN: 2054-5703
Titre abrégé: R Soc Open Sci
Pays: England
ID NLM: 101647528
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
17
03
2021
accepted:
02
09
2021
entrez:
16
9
2021
pubmed:
17
9
2021
medline:
17
9
2021
Statut:
epublish
Résumé
We examined the extent to which the scientific workforce in different fields was engaged in publishing COVID-19-related papers. According to Scopus (data cut, 1 August 2021), 210 183 COVID-19-related publications included 720 801 unique authors, of which 360 005 authors had published at least five full papers in their career and 23 520 authors were at the top 2% of their scientific subfield based on a career-long composite citation indicator. The growth of COVID-19 authors was far more rapid and massive compared with cohorts of authors historically publishing on H1N1, Zika, Ebola, HIV/AIDS and tuberculosis. All 174 scientific subfields had some specialists who had published on COVID-19. In 109 of the 174 subfields of science, at least one in 10 active, influential (top 2% composite citation indicator) authors in the subfield had authored something on COVID-19. Fifty-three hyper-prolific authors had already at least 60 (and up to 227) COVID-19 publications each. Among the 300 authors with the highest composite citation indicator for their COVID-19 publications, most common countries were USA (
Identifiants
pubmed: 34527271
doi: 10.1098/rsos.210389
pii: rsos210389
pmc: PMC8422596
doi:
Banques de données
figshare
['10.6084/m9.figshare.c.5604743']
Types de publication
Journal Article
Langues
eng
Pagination
210389Informations de copyright
© 2021 The Authors.
Références
BMJ Evid Based Med. 2021 Dec;26(6):302-306
pubmed: 32998992
Nature. 2013 Oct 10;502(7470):S2-3
pubmed: 24108078
Science. 2020 May 1;368(6490):476-477
pubmed: 32327600
Cureus. 2020 Nov 5;12(11):e11346
pubmed: 33304681
Eur J Clin Invest. 2020 Apr;50(4):e13222
pubmed: 32191341
Trials. 2021 Mar 5;22(1):188
pubmed: 33673845
R Soc Open Sci. 2021 Sep 7;8(9):210389
pubmed: 34527271
J Clin Epidemiol. 2021 Jul;135:17-28
pubmed: 33657455
PLoS One. 2021 Feb 2;16(2):e0246427
pubmed: 33529266
BMC Med. 2021 Feb 23;19(1):46
pubmed: 33618741
J Med Ethics. 2020 Dec;46(12):803-807
pubmed: 33004545
J Epidemiol Community Health. 2020 Sep;74(9):766-767
pubmed: 32631844
Radiol Cardiothorac Imaging. 2020 Jul 30;2(4):e200342
pubmed: 33778613
Brain Behav Immun Health. 2020 Aug;7:100123
pubmed: 32835299
Nature. 2020 Dec;588(7838):381-382
pubmed: 33268880
PLoS Biol. 2020 Oct 16;18(10):e3000918
pubmed: 33064726
Nature. 2020 Jun;582(7811):160
pubmed: 32504025
Science. 2020 Feb 28;367(6481):963-964
pubmed: 32108094
J Evid Based Med. 2021 Feb;14(1):40-55
pubmed: 33565225
Ann Transl Med. 2021 Apr;9(8):633
pubmed: 33987331
Nature. 2018 Sep;561(7722):167-169
pubmed: 30209384
Nat Med. 2020 Aug;26(8):1159
pubmed: 32719486
Lancet. 2020 Feb 29;395(10225):676
pubmed: 32113495
BMJ Evid Based Med. 2021 Jun 3;:
pubmed: 34083212
BMC Med. 2020 Jun 25;18(1):192
pubmed: 32586327
Sci Rep. 2020 Oct 6;10(1):16598
pubmed: 33024152
PLoS One. 2020 Oct 6;15(10):e0240123
pubmed: 33022014
J Clin Epidemiol. 2021 Jul 2;:107-120
pubmed: 34224834
PLoS Biol. 2016 Jul 01;14(7):e1002501
pubmed: 27367269
J Clin Epidemiol. 2020 Jul;123:120-126
pubmed: 32330521
Learn Publ. 2021 Jun 01;:
pubmed: 34226800
Account Res. 2021 Jan;28(1):58-59
pubmed: 32634321